1997
DOI: 10.1016/s0890-6238(97)00065-8
|View full text |Cite
|
Sign up to set email alerts
|

Initial uterine alterations caused by developmental exposure to tamoxifen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
9
0

Year Published

2000
2000
2011
2011

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(10 citation statements)
references
References 34 publications
1
9
0
Order By: Relevance
“…Although increased PRL release is a well characterized effect of estrogens, serum PRL levels in adult mice, neonatally treated with DES, were unchanged (27,28). These reports agree with our observation that DES, at a dose similar to that used by others (27)(28)(29)(30), causes only a transient rise in serum PRL levels in prepubertal male and female rats. Despite having a 10,000-fold higher binding affinity to the ER than the xenoestrogens, DES had only modest effects on receptor expression in the neuroendocrine system.…”
Section: Discussionsupporting
confidence: 92%
“…Although increased PRL release is a well characterized effect of estrogens, serum PRL levels in adult mice, neonatally treated with DES, were unchanged (27,28). These reports agree with our observation that DES, at a dose similar to that used by others (27)(28)(29)(30), causes only a transient rise in serum PRL levels in prepubertal male and female rats. Despite having a 10,000-fold higher binding affinity to the ER than the xenoestrogens, DES had only modest effects on receptor expression in the neuroendocrine system.…”
Section: Discussionsupporting
confidence: 92%
“…In favour of this hypothesis are the following facts: (1) perinatal treatment of male rats with tamoxifen caused reproductive tract lesions and sexual behaviour deficits similar to those induced by diethylstilboestrol (DES; a synthetic compound with oestrogenic activity) , (2) tamoxifen administered neonatally showed uterotrophic action similar to DES (Poulet et al 1997), (3) the effects of raloxifene and oestradiol given neonatally to female and male rats were similar (Pinilla et al 2001a), (4) raloxifene showed, in adult ovariectomized females, an oestrogen-like action evidenced by the reduction in LH secretion and the increase of prolactin release (Pinilla et al 2001b) and (5) raloxifene was unable to block the effects of oestradiol and testosterone given neonatally.…”
Section: Discussionmentioning
confidence: 99%
“…At the same time, they act as estrogen agonists in the bone and cardiovascular system, where they counteract osteoporosis and coronary syndromes. Finally, in the uterus, tamoxifen shows a similar activity to estrogen and for this reason is associated to a higher risk of endometrial carcinoma [56,59].…”
Section: Phytoestrogensmentioning
confidence: 99%